Biotech | June 08, 2023
Bayer partners with biotech firm on lipid nanoparticle delivery systems
Acuitas Therapeutics' LNP technology will support Bayer’s in vivo gene editing and protein replacement programs with the goal of specifically delivering RNA payloads to the desired target organ, the liver.
